| __timestamp | Teva Pharmaceutical Industries Limited | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 1488000000 | 15411924 |
| Thursday, January 1, 2015 | 1525000000 | 22593274 |
| Friday, January 1, 2016 | 2111000000 | 33173050 |
| Sunday, January 1, 2017 | 1848000000 | 62224159 |
| Monday, January 1, 2018 | 1213000000 | 95607434 |
| Tuesday, January 1, 2019 | 1010000000 | 221269028 |
| Wednesday, January 1, 2020 | 997000000 | 400745069 |
| Friday, January 1, 2021 | 967000000 | 580520000 |
| Saturday, January 1, 2022 | 838000000 | 663366000 |
| Sunday, January 1, 2023 | 953000000 | 755113687 |
| Monday, January 1, 2024 | 998000000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, two industry giants, Teva Pharmaceutical Industries Limited and argenx SE, have showcased contrasting R&D trajectories.
Teva, a stalwart in the industry, has seen its R&D expenses decline by approximately 36% from 2014 to 2023, reflecting strategic shifts and market challenges. In contrast, argenx SE, a rising star, has increased its R&D investment by an astounding 4,800% over the same period, underscoring its commitment to pioneering therapies.
This divergence highlights the dynamic nature of pharmaceutical R&D, where established players and emerging innovators navigate distinct paths. As we look to the future, these trends offer a glimpse into the strategic priorities shaping the next wave of medical breakthroughs.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Alnylam Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Dr. Reddy's Laboratories Limited
argenx SE or Opthea Limited: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and ADMA Biologics, Inc.
Research and Development Investment: argenx SE vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
R&D Spending Showdown: argenx SE vs Veracyte, Inc.
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.